Inventor · disambiguated record
Yossi Dagon
Also filed as: DAGON YOSSI
11 granted patents·7 pending applications·12 citations·filing 2004–2024
85Inventor score
Files withACCELERON PHARMA INC11BERRY ELLIOT2ACCELERON PHARM INC1GOLDFINCH BIO INC1RUBINSTEIN MENACHEM1
Top patents by PatentIndex Score
18 records- 0193US11028145B2ALK7:actriib heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2019·Granted Jun 8, 2021·4 cites·23 claims
- 0290US10501547B2ALK7 binding proteins and uses thereofACCELERON PHARMA INC·Filed 2017·Granted Dec 10, 2019·3 cites·7 claims
- 0386US10227392B2ALK7:ActRIIB heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2016·Granted Mar 12, 2019·3 cites·29 claims
- 0484US2024309098A1Alk7 antagonists and uses thereofACCELERON PHARM INC·Filed 2024·Application pending·0 cites
- 0583US11059894B2ALK7 binding proteins and uses thereofACCELERON PHARMA INC·Filed 2019·Granted Jul 13, 2021·1 cites·7 claims
- 0682US2023416379A1ALK7 Binding Proteins and Uses ThereofACCELERON PHARMA INC·Filed 2023·Application pending·0 cites
- 0778US12024563B2ALK7 antagonists and uses thereofACCELERON PHARMA INC·Filed 2021·Granted Jul 2, 2024·0 cites·12 claims
- 0878US11827689B2ALK7:ActRIIB heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2021·Granted Nov 28, 2023·0 cites·21 claims
- 0977US11708414B2ALK7 binding proteins and uses thereofACCELERON PHARMA INC·Filed 2021·Granted Jul 25, 2023·0 cites·7 claims
- 1065US10166202B2Treatment of hepatic encephalopathy and liver cirrhosisBERRY ELLIOT·Filed 2011·Granted Jan 1, 2019·1 cites·4 claims
- 1163US2020048355A1Alk7 antagonists and uses thereofACCELERON PHARMA INC·Filed 2019·Application pending·0 cites
- 1261US2010022631A1Treatment of hepatic encephalopathy and liver cirrhosisYISSUM RES DEV CO·Filed 2009·Application pending·0 cites
- 1357US2017306027A1Alk7 antagonists and uses thereofACCELERON PHARMA INC·Filed 2017·Application pending·0 cites
- 1452US12365736B2ALK7 binding proteins and uses thereofACCELERON PHARMA INC·Filed 2020·Granted Jul 22, 2025·0 cites·20 claims
- 1552US2006166957A1Methods of treating obesity and related disorders using tellurium selenium compoundsRUBINSTEIN MENACHEM·Filed 2004·Application pending·0 cites
- 1648US2024091303A1Biomarker-based treatment of focal segmental glomerulosclerosis and diabetic kidney diseaseGOLDFINCH BIO INC·Filed 2020·Application pending·0 cites
- 1746US11439673B2Bacteria engineered to treat liver diseaseSYNLOGIC OPERATING CO INC·Filed 2019·Granted Sep 13, 2022·0 cites·22 claims
- 1835US9333240B2Compounds for improving nutritional status, cognition and survivalBERRY ELLIOT·Filed 2006·Granted May 10, 2016·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →